Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
MCRP vs NBTB vs FFIN vs IBCP vs CZWI
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
MCRP vs NBTB vs FFIN vs IBCP vs CZWI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $90M | $2.35B | $4.61B | $699M | $203M |
| Revenue (TTM) | $130K | $867M | $739M | $315M | $90M |
| Net Income (TTM) | $-22M | $169M | $243M | $69M | $14M |
| Gross Margin | 56.0% | 72.1% | 70.8% | 69.6% | 54.7% |
| Operating Margin | -162.3% | 25.3% | 36.8% | 25.8% | 7.0% |
| Forward P/E | — | 10.8x | 15.9x | 9.6x | 11.8x |
| Total Debt | $8M | $327M | $197M | $117M | $52M |
| Cash & Equiv. | $48K | $185M | $763M | $52M | $119M |
MCRP vs NBTB vs FFIN vs IBCP vs CZWI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 25 | May 26 | Return |
|---|---|---|---|
| Micropolis AI Robot… (MCRP) | 100 | 86.0 | -14.0% |
| NBT Bancorp Inc. (NBTB) | 100 | 105.1 | +5.1% |
| First Financial Ban… (FFIN) | 100 | 90.2 | -9.8% |
| Independent Bank Co… (IBCP) | 100 | 110.3 | +10.3% |
| Citizens Community … (CZWI) | 100 | 146.6 | +46.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MCRP vs NBTB vs FFIN vs IBCP vs CZWI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, MCRP doesn't own a clear edge in any measured category.
NBTB ranks third and is worth considering specifically for income & stability and valuation efficiency.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- PEG 1.53 vs FFIN's 3.05
- 3.2% yield, 12-year raise streak, vs CZWI's 1.8%, (1 stock pays no dividend)
FFIN carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 18.8%, EPS growth 12.2%
- 18.8% NII/revenue growth vs MCRP's -77.5%
- 30.2% margin vs MCRP's -171.4%
- 1.6% ROA vs MCRP's -241.3%
IBCP is the clearest fit if your priority is long-term compounding and defensive.
- 184.6% 10Y total return vs CZWI's 157.0%
- Beta 0.83, yield 3.0%, current ratio 370.62x
- NIM 3.3% vs CZWI's 2.9%
- Lower P/E (9.6x vs 15.9x), PEG 1.82 vs 3.05
CZWI is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.46, Low D/E 27.6%, current ratio 3015.31x
- Beta 0.46 vs MCRP's 1.69
- +45.6% vs MCRP's -18.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.8% NII/revenue growth vs MCRP's -77.5% | |
| Value | Lower P/E (9.6x vs 15.9x), PEG 1.82 vs 3.05 | |
| Quality / Margins | 30.2% margin vs MCRP's -171.4% | |
| Stability / Safety | Beta 0.46 vs MCRP's 1.69 | |
| Dividends | 3.2% yield, 12-year raise streak, vs CZWI's 1.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +45.6% vs MCRP's -18.9% | |
| Efficiency (ROA) | 1.6% ROA vs MCRP's -241.3% |
MCRP vs NBTB vs FFIN vs IBCP vs CZWI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MCRP vs NBTB vs FFIN vs IBCP vs CZWI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FFIN leads in 2 of 6 categories
IBCP leads 1 • CZWI leads 1 • NBTB leads 1 • MCRP leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
FFIN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 6670.4x MCRP's $130,043. FFIN is the more profitable business, keeping 30.2% of every revenue dollar as net income compared to MCRP's -171.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $130,043 | $867M | $739M | $315M | $90M |
| EBITDAEarnings before interest/tax | — | $241M | $310M | $89M | $9M |
| Net IncomeAfter-tax profit | — | $169M | $243M | $69M | $14M |
| Free Cash FlowCash after capex | — | $225M | $290M | $70M | $11M |
| Gross MarginGross profit ÷ Revenue | +56.0% | +72.1% | +70.8% | +69.6% | +54.7% |
| Operating MarginEBIT ÷ Revenue | -162.3% | +25.3% | +36.8% | +25.8% | +7.0% |
| Net MarginNet income ÷ Revenue | -171.4% | +19.5% | +30.2% | +21.7% | +16.0% |
| FCF MarginFCF ÷ Revenue | -116.7% | +25.2% | +39.6% | +22.2% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -45.9% | +39.5% | -7.7% | +2.3% | +63.0% |
Valuation Metrics
IBCP leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 10.4x trailing earnings, IBCP trades at a 50% valuation discount to FFIN's 20.8x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 1.92x vs FFIN's 3.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $90M | $2.4B | $4.6B | $699M | $203M |
| Enterprise ValueMkt cap + debt − cash | $92M | $2.5B | $4.0B | $764M | $136M |
| Trailing P/EPrice ÷ TTM EPS | -14.30x | 13.53x | 20.76x | 10.38x | 14.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.80x | 15.92x | 9.56x | 11.78x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.92x | 3.98x | 1.97x | 2.85x |
| EV / EBITDAEnterprise value multiple | — | 10.35x | 14.17x | 9.39x | 15.28x |
| Price / SalesMarket cap ÷ Revenue | 2532.10x | 2.71x | 6.23x | 2.22x | 2.25x |
| Price / BookPrice ÷ Book value/share | — | 1.21x | 2.89x | 1.41x | 1.09x |
| Price / FCFMarket cap ÷ FCF | — | 10.75x | 15.73x | 9.96x | 19.55x |
Profitability & Efficiency
FFIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
IBCP delivers a 14.2% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $8 for CZWI. FFIN carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to CZWI's 0.28x. On the Piotroski fundamental quality scale (0–9), IBCP scores 8/9 vs MCRP's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +9.5% | +13.3% | +14.2% | +7.8% |
| ROA (TTM)Return on assets | -2.4% | +1.1% | +1.6% | +1.3% | +0.8% |
| ROICReturn on invested capital | — | +7.9% | +11.0% | +10.2% | +2.0% |
| ROCEReturn on capital employed | — | +2.4% | +16.0% | +2.6% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 | 8 | 6 |
| Debt / EquityFinancial leverage | — | 0.17x | 0.12x | 0.23x | 0.28x |
| Net DebtTotal debt minus cash | $8M | $142M | -$566M | $65M | -$67M |
| Cash & Equiv.Liquid assets | $47,837 | $185M | $763M | $52M | $119M |
| Total DebtShort + long-term debt | $8M | $327M | $197M | $117M | $52M |
| Interest CoverageEBIT ÷ Interest expense | -17.48x | 1.05x | 1.48x | 0.91x | 0.16x |
Total Returns (Dividends Reinvested)
CZWI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CZWI five years ago would be worth $17,124 today (with dividends reinvested), compared to $7,178 for FFIN. Over the past 12 months, CZWI leads with a +45.6% total return vs MCRP's -18.9%. The 3-year compound annual growth rate (CAGR) favors CZWI at 37.5% vs MCRP's -10.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +58.6% | +9.3% | +8.5% | +7.2% | +21.5% |
| 1-Year ReturnPast 12 months | -18.9% | +9.0% | -3.2% | +12.6% | +45.6% |
| 3-Year ReturnCumulative with dividends | -27.6% | +54.1% | +29.1% | +130.6% | +160.0% |
| 5-Year ReturnCumulative with dividends | -27.6% | +29.9% | -28.2% | +63.7% | +71.2% |
| 10-Year ReturnCumulative with dividends | -27.6% | +102.2% | +145.4% | +184.6% | +157.0% |
| CAGR (3Y)Annualised 3-year return | -10.2% | +15.5% | +8.9% | +32.1% | +37.5% |
Risk & Volatility
Evenly matched — NBTB and CZWI each lead in 1 of 2 comparable metrics.
Risk & Volatility
CZWI is the less volatile stock with a 0.46 beta — it tends to amplify market swings less than MCRP's 1.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NBTB currently trades 96.1% from its 52-week high vs MCRP's 55.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.69x | 0.89x | 0.95x | 0.83x | 0.46x |
| 52-Week HighHighest price in past year | $4.62 | $46.92 | $38.74 | $37.39 | $22.62 |
| 52-Week LowLowest price in past year | $0.69 | $39.20 | $28.11 | $29.63 | $12.83 |
| % of 52W HighCurrent price vs 52-week peak | +55.7% | +96.1% | +83.6% | +90.8% | +93.2% |
| RSI (14)Momentum oscillator 0–100 | 52.8 | 57.3 | 58.2 | 50.6 | 63.7 |
| Avg Volume (50D)Average daily shares traded | 122K | 236K | 740K | 176K | 40K |
Analyst Outlook
NBTB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NBTB as "Hold", FFIN as "Hold", IBCP as "Hold", CZWI as "Buy". Consensus price targets imply 21.2% upside for FFIN (target: $39) vs 2.1% for NBTB (target: $46). For income investors, NBTB offers the higher dividend yield at 3.17% vs CZWI's 1.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $46.00 | $39.25 | $38.00 | — |
| # AnalystsCovering analysts | — | 10 | 15 | 7 | 2 |
| Dividend YieldAnnual dividend ÷ price | — | +3.2% | +2.2% | +3.0% | +1.8% |
| Dividend StreakConsecutive years of raises | — | 12 | 11 | 11 | 7 |
| Dividend / ShareAnnual DPS | — | $1.43 | $0.72 | $1.03 | $0.37 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.4% | 0.0% | +1.8% | +3.1% |
FFIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IBCP leads in 1 (Valuation Metrics). 1 tied.
MCRP vs NBTB vs FFIN vs IBCP vs CZWI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MCRP or NBTB or FFIN or IBCP or CZWI a better buy right now?
For growth investors, First Financial Bankshares, Inc.
(FFIN) is the stronger pick with 18. 8% revenue growth year-over-year, versus -77. 5% for Micropolis AI Robotics (MCRP). Independent Bank Corporation (IBCP) offers the better valuation at 10. 4x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate Citizens Community Bancorp, Inc. (CZWI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MCRP or NBTB or FFIN or IBCP or CZWI?
On trailing P/E, Independent Bank Corporation (IBCP) is the cheapest at 10.
4x versus First Financial Bankshares, Inc. at 20. 8x. On forward P/E, Independent Bank Corporation is actually cheaper at 9. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NBT Bancorp Inc. wins at 1. 53x versus First Financial Bankshares, Inc. 's 3. 05x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — MCRP or NBTB or FFIN or IBCP or CZWI?
Over the past 5 years, Citizens Community Bancorp, Inc.
(CZWI) delivered a total return of +71. 2%, compared to -28. 2% for First Financial Bankshares, Inc. (FFIN). Over 10 years, the gap is even starker: IBCP returned +184. 6% versus MCRP's -27. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MCRP or NBTB or FFIN or IBCP or CZWI?
By beta (market sensitivity over 5 years), Citizens Community Bancorp, Inc.
(CZWI) is the lower-risk stock at 0. 46β versus Micropolis AI Robotics's 1. 69β — meaning MCRP is approximately 268% more volatile than CZWI relative to the S&P 500. On balance sheet safety, First Financial Bankshares, Inc. (FFIN) carries a lower debt/equity ratio of 12% versus 28% for Citizens Community Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MCRP or NBTB or FFIN or IBCP or CZWI?
By revenue growth (latest reported year), First Financial Bankshares, Inc.
(FFIN) is pulling ahead at 18. 8% versus -77. 5% for Micropolis AI Robotics (MCRP). On earnings-per-share growth, the picture is similar: NBT Bancorp Inc. grew EPS 12. 5% year-over-year, compared to -43. 5% for Micropolis AI Robotics. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MCRP or NBTB or FFIN or IBCP or CZWI?
First Financial Bankshares, Inc.
(FFIN) is the more profitable company, earning 30. 2% net margin versus -171. 4% for Micropolis AI Robotics — meaning it keeps 30. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FFIN leads at 36. 8% versus -162. 3% for MCRP. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MCRP or NBTB or FFIN or IBCP or CZWI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NBT Bancorp Inc. (NBTB) is the more undervalued stock at a PEG of 1. 53x versus First Financial Bankshares, Inc. 's 3. 05x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Independent Bank Corporation (IBCP) trades at 9. 6x forward P/E versus 15. 9x for First Financial Bankshares, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FFIN: 21. 2% to $39. 25.
08Which pays a better dividend — MCRP or NBTB or FFIN or IBCP or CZWI?
In this comparison, NBTB (3.
2% yield), IBCP (3. 0% yield), FFIN (2. 2% yield), CZWI (1. 8% yield) pay a dividend. MCRP does not pay a meaningful dividend and should not be held primarily for income.
09Is MCRP or NBTB or FFIN or IBCP or CZWI better for a retirement portfolio?
For long-horizon retirement investors, Citizens Community Bancorp, Inc.
(CZWI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 46), 1. 8% yield, +157. 0% 10Y return). Micropolis AI Robotics (MCRP) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CZWI: +157. 0%, MCRP: -27. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MCRP and NBTB and FFIN and IBCP and CZWI?
These companies operate in different sectors (MCRP (Technology) and NBTB (Financial Services) and FFIN (Financial Services) and IBCP (Financial Services) and CZWI (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MCRP is a small-cap quality compounder stock; NBTB is a small-cap deep-value stock; FFIN is a small-cap high-growth stock; IBCP is a small-cap deep-value stock; CZWI is a small-cap deep-value stock. NBTB, FFIN, IBCP, CZWI pay a dividend while MCRP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.